A Clinical Trial of CK0801 (a New Drug) In Patients With Treatment-Resistant Guillain-Barré Syndrome (GBS)

NCT03773328 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Pending contract negotiations

Conditions

Guillain-Barré Syndrome

Interventions

BIOLOGICAL: CK0801

Sponsor

Cellenkos, Inc.